It is worth noting that RIT1 is frequently amplified in various human cancers including HCC, lung adenocarcinoma, cholangiocarcinoma, uterine carcinosarcoma, breast cancer, and ovarian cancer [15, 21]. This evidence concerns the gene RIT1 and hepatocellular carcinoma.